Apolipoprotein E genotype and gender influence response to tacrine therapy

被引：67

作者：

Farlow, MR

Lahiri, DK

Poirier, J

Davignon, J

Hui, S

机构：

[1] INDIANA UNIV,SCH MED,DEPT PSYCHIAT,INDIANAPOLIS,IN 46202

[2] INDIANA UNIV,SCH MED,DEPT MED,INDIANAPOLIS,IN 46202

[3] MCGILL UNIV,MONTREAL,PQ,CANADA

[4] CLIN RES INST MONTREAL,MONTREAL,PQ H2W 1R7,CANADA

来源：

APOLIPOPROTEIN E GENOTYPING IN ALZHEIMER'S DISEASE | 1996年 / 802卷

关键词：

D O I：

10.1111/j.1749-6632.1996.tb32603.x

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：101 / 110

页数：10

共 25 条

[1]

[Anonymous], 1976, ECDEU Assessment Manual for Psychopharmacology

[2] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].

CORDER, EH ;

SAUNDERS, AM ;

STRITTMATTER, WJ ;

SCHMECHEL, DE ;

GASKELL, PC ;

SMALL, GW ;

ROSES, AD ;

HAINES, JL ;

PERICAKVANCE, MA .

SCIENCE, 1993, 261 (5123) :921-923

[3]

CORDER EH, 1995, JAMA-J AM MED ASSOC, V273, P373, DOI 10.1001/jama.273.5.373

[4] A CONTROLLED TRIAL OF TACRINE IN ALZHEIMERS-DISEASE [J].

FARLOW, M ;

GRACON, SI ;

HERSHEY, LA ;

LEWIS, KW ;

SADOWSKY, CH ;

DOLANURENO, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 268 (18) :2523-2529

[5] APOLIPOPROTEIN-E GENOTYPE IN PATIENTS WITH ALZHEIMERS-DISEASE - IMPLICATIONS FOR THE RISK OF DEMENTIA AMONG RELATIVES [J].

FARRER, LA ;

CUPPLES, LA ;

VANDUIJN, CM ;

KURZ, A ;

ZIMMER, R ;

MULLER, U ;

GREEN, RC ;

CLARKE, V ;

SHOFFNER, R ;

WALLACE, DC ;

CHUI, H ;

FLANAGAN, SD ;

DUARA, R ;

STGEORGEHYSLOP, P ;

AUERBACH, SA ;

VOLICER, L ;

WELLS, JM ;

VAN BROECKHOVEN, C ;

GROWDON, JH ;

HAINES, JL .

ANNALS OF NEUROLOGY, 1995, 38 (05) :797-808

[6] MINI-MENTAL STATE - PRACTICAL METHOD FOR GRADING COGNITIVE STATE OF PATIENTS FOR CLINICIAN [J].

FOLSTEIN, MF ;

FOLSTEIN, SE ;

MCHUGH, PR .

JOURNAL OF PSYCHIATRIC RESEARCH, 1975, 12 (03) :189-198

[7]

FRIZONI GB, 1995, ANN NEUROL, V37, P596

[8]

HEFTI F, 1989, PSYCHIATRIC DEV, V4, P297

[9] Progress in molecular genetics of Alzheimer's disease [J].

Hisama, FM ;

Schellenberg, GD .

NEUROSCIENTIST, 1996, 2 (01) :3-6

[10] A 30-WEEK RANDOMIZED CONTROLLED TRIAL OF HIGH-DOSE TACRINE IN PATIENTS WITH ALZHEIMERS-DISEASE [J].

KNAPP, MJ ;

KNOPMAN, DS ;

SOLOMON, PR ;

PENDLEBURY, WW ;

DAVIS, CS ;

GRACON, SI ;

APTER, JT ;

LAZARUS, CN ;

BAKER, KE ;

BARNETT, M ;

BAUMEL, B ;

EISNER, LS ;

CASTELLS, B ;

BOLOURI, R ;

BENNETT, D ;

FORCHETTI, C ;

LEVIN, A ;

BLASS, JP ;

NOLAN, KA ;

GAINES, ER ;

RELKIN, N ;

BORISON, RL ;

DIAMOND, B ;

CELESIA, GG ;

ROSS, AP ;

DEXTER, J ;

DOODY, R ;

LIPSCOMB, L ;

KREITER, K ;

DUBOFF, EA ;

BLOCK, P ;

MARSHALL, D ;

WESTERGAARD, N ;

EARL, NL ;

WYNE, SV ;

HINMANSMITH, E ;

FARLOW, M ;

HENDRIE, HC ;

CARESS, JA ;

FARMER, M ;

HARPER, JE ;

FERGUSON, J ;

FOSTER, NL ;

BARBAS, NR ;

BLUEMLEIN, LA ;

GELB, DJ ;

BERENT, S ;

GIORDANI, B ;

GREENWALD, M ;

BERGMAN, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (13) :985-991

← 1 2 3 →